The research at IMBA aims to understand the fundamental molecular biological processes underlying the 3D architecture of genomes, the functions of small RNAs, and the in vitro reconstitution from stem cells of whole organs and embryos.[2]
The institute comprises 14 research groups (as of July 2024):[3]
Stefan Ameres (adjunct group): Mechanism and biology of RNA silencing. Developer of the SLAMseq technology.[4]
Nicolas Rivron: Blastoid development and implantation. Developer of the blastoid, a complete embryo model.[7]
Shambaditya Saha: Macromolecular phase separation in germ cell fate.
Elly Tanaka: Molecular mechanisms of vertebrate regeneration.
Noelia Urbán: Systemic regulation of adult neurogenesis.
Associated projects: The Vienna Drosophila RNAi Center (VDRC) is located at IMBA, and is available to researchers worldwide.[8] It collects an RNAi library of over 22,000 Drosophila strains.
2021. Human blastoids model blastocyst development and implantation[12]
2021. Cardioids reveal self-organizing principles of human cardiogenesis[13]
2020. Identification of a brain-size determinant using cerebral organoids[14]
2020. Discovery on the conformation of sister chromatids in the replicated human genome[15]
2019. Generation of blood vessel organoids from human pluripotent stem cells.[16]
2017. Development of SLAM-Seq for the high-resolution assessment of RNA expression dynamics[17]
2017. Development of a reversible haploid mouse pluripotent stem cell biobank resource for functional genomics.[18]
2013. Generation of cerebral organoids from human pluripotent stem cells to model human brain development[19]
2008. Discovery of an endogenous small interfering RNA pathway in Drosophila.[20]
2005. Discovery of the role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury.[21]
History
The institute was founded in 1999 as a joint initiative of the Austrian Academy of Sciences and Boehringer Ingelheim and with contributions from the Austrian Government and the city of Vienna.[22] The construction of the building was initiated in 2003 and completed in 2006. It is linked to the building of the Research Institute of Molecular Pathology by a bridge so as to enhance collaborations. Both institutes share a common canteen and their scientific core facilities. In 2002, the geneticist Josef Penninger started as the Scientific Director of the IMBA and recruited Barry Dickson as the first group leader (now at Janelia Research Campus, USA). In 2007 the Vienna Drosophila RNAi Center (VDRC) opened, in collaboration with the Research Institute of Molecular Pathology. In 2018, Josef Penninger was appointed as director of the Life Science Institute of the University of British Columbia[23] and Jürgen Knoblich took the position as interim director of IMBA. In 2020, the institute expanded in an additional building of the Vienna Biocenter (termed VBC6). In 2024, Elly Tanaka took the position as Scientific Director of IMBA.
Core scientific facilities within the IMBA provide services to facilitate research making use of stem cells, flies/worms, informatics, optics, molecular biology, comparative medicine, transgenics, protein chemistry, or graphic designs. These core facilities are managed by technical leaders who evaluate and implement a wide range of novel technologies and instrumentations. These professional staff scientists also train users, help with experimental design, and disseminate expert knowledge. The IMBA scientists are not billed for core services, except for certain experiment-related consumables.
Beyond the core scientific facilities of the institute, the IMBA laboratories are also financially supported to use of the core facilities of the Vienna Biocenter.
Seminar and conferences
The IMBA acts as a forum for academic exchange through its participation to a series of weekly internal Vienna Biocenter seminars, and weekly guest lectures (termed "VBC lectures" and "Impromptus") from external, recognised or upcoming scientists.
IMBA and the IMP co-organize the yearly SY-Stem symposium focusing on the next generation of stem cell researchers.
PhD program
The Vienna Biocenter PhD Programme is an international PhD training program carried out jointly by the four Vienna Biocenter research institutes (IMP, IMBA, GMI and Max Perutz Labs). Acceptance into the program is competitive and based on a formal selection procedure. There are two selections each year, deadlines are usually on April 30 and November 15. Participation in the program is a condition for doing a PhD at the IMBA.
Awards
TIMBA has received recognition in the form of 18 ERC grants and through awards to its researchers.
Josef Penninger, former scientific director, has been elected as a full member of The Austrian Academy of Sciences (ÖAW).[35] He has been awarded the Ernst Jung Prize for Medicine by the Jung-Stiftung for Science and Research, the Descartes Prize for Research by the European Commission and has received the Carus-Medal of the German Academy of Sciences Leopoldina. In 2012, Josef Penninger was awarded with the Innovator Award for his project "Novel Approaches to Breast Cancer Prevention and Inhibition of Metastases" through the US Department of Defense.[36] In 2013 Josef Penninger received his second European Research Council’s (ERC) Advanced Investigator Grant for his research in the field of haploidstem cells.[37]
Science communication
In collaboration with the incorporated society Dialog Gentechnik, in 2006 IMBA opened a hands-on biomolecular laboratory open to the public.[38]